梅州打胎手术费一般多少钱(梅州急性附件炎可以诊治吗) (今日更新中)

GREENCASTLE, Ind. — Several dozen students interrupted an event featuring actress Jenna Fischer at DePauw University Tuesday to protests recent racial incidents on and near campus.Many of them held signs with things claiming they are "afraid for their lives" after recent events. Fischer, star of the sicoms "The Office" and "Splitting Up Together" was at the university to discuss her new book, "The Actor's Life: A Survivor's Guide."University Spokesman Ken Owen, who was moderating the lecture with Fischer, said about 15 minutes into the program a group of students got up and began interrupting the event whistling, shouting and saying they were afraid for their safety on campus because of the recent racial incidents. Last week, a hateful message was found written in a bathroom at the university. The message, which read " All ******* must die -KKK," was written on a bathroom wall of the Inn at DePauw, a public building on campus. Another anti-Semitic and homophobic messages were also found. The video above was captured during the Tuesday evening protests by Shannon Samson. Another event being investigated by the university involves a hateful slur written in rocks at the DePauw nature park, which is owned by the university. Owen said there was a meeting with the school president Tuesday over the events and that have happened up until that point and they expect more meetings in the future. DePauw University issued the following statement on social media after the event.  1573

Having an adequate supply of personal protective equipment could have saved the state of California hundreds of millions of dollars and stopped roughly 18,000 essential workers from getting the coronavirus, according to a new study from the University of California Berkeley.Researchers at the school looked at the cost of PPE and the early costs and infection rates of coronavirus in California. They conclude with a recommendation that the state stockpile PPE for a future pandemic.The team’s first data point is based on supply and demand; purchasing PPE when it is not high in demand, then saving it for when it's needed. According to the study, the cost of purchasing the same amount of PPE when there was not a global demand would be 17 percent of what the projected cost is now during the pandemic.“Maintaining the stockpile would be cheaper than real-time purchases even if it was not needed for another 35 years, and even if we were fortunate enough to not need the stockpile for longer than that, it would be a highly financially prudent form of insurance,” the researchers stated.Between mid-March and mid-July, roughly 250,000 healthcare workers in California filed for unemployment benefits because there was not sufficient PPE for them to go to work.For each week those healthcare workers could not report to work, it cost the state million in unemployment benefits. The researchers conclude millions could be saved by having the personal protective equipment available.Looking at rates of infection and studies from Europe showing transmission rates at hospitals, Berkeley researches believe almost 18,000 coronavirus cases among essential workers could have been prevented with an adequate supply of PPE.“If those worker cases had been avoided, an estimated 3,030 secondary cases among household members could have also been avoided, thus totaling at least 20,860 cases that could have been averted,” the study states.A separate survey conducted in June and July asked California’s skilled nursing facility staff about equipment; more than 20 percent reported still having inadequate supplies of PPE, and 80 percent said they were very or extremely concerned about workplace infection.The Berkeley study also appears to give support to California Senate Bill 275 as amended in July 2020, that “would require the state to create a PPE stockpile sufficient to protect healthcare and other essential workers for at least 90-days of a future pandemic or health emergency.” 2496

HARRISBURG, Pa. (AP) — Comedian Bill Cosby has won the right to fight his 2018 sexual assault conviction before the Pennsylvania Supreme Court. The 82-year-old Cosby has been imprisoned in suburban Philadelphia for nearly two years after a jury convicted him of drugging and sexually assaulting a woman in 2004. He's serving a three- to 10-year sentence.The Supreme Court has agreed to review two aspects of the case that Cosby's lawyers challenge. The first involves the judge's decision to let prosecutors call five other accusers. And the court will examine Cosby's argument that he had an agreement with a former prosecutor that he'd never be charged. 663

GULF SHORES, Ala. – An Alabama woman says Hurricane Sally brought more than strong winds and heavy rains to her area.Tina Lambert Bennett spotted an alligator in the storm surge and captured the encounter on video.Bennett says she was upstairs in her Gulf Shores property, surveying the damage, when she spotted the gator in her yard.She believes the animal was at least 3.5 feet wide and 11 to 12 feet long.When the hurricane hit, surrounding canals overflowed and filled the marshlands.Bennett says she wants people to be aware of what can be in the water.It's not just alligators. She says there are also poisonous snakes in the area. 645

Holidays will look different this year for many Americans, with dinners outside, social distancing, or passing on family gatherings altogether. But several companies developing rapid at-home COVID-19 tests are hopeful that won't be the case next year. The goal is to make inexpensive, easy-to-use COVID tests that can deliver results in minutes, just like a pregnancy test. "For people to feel comfortable to associate with friends or family, there needs to be a testing methodology ideally that can be performed at home," said Tony Lemmo, CEO of the manufacturing company BioDot.The company's technology is being used by over 70 manufacturers worldwide making COVID-19 antigen, antibody, and PCR tests. Their automated platforms dispense nanoliter/picoliter amounts of reagent onto the tests accurately and fast.Lemmo says just one of their systems can support the production of roughly 100 million COVID-19 tests per year, helping to make high-volume production possible.“We knew we were going to be called on by customers to manufacture more equipment to provide them the ability to manufacture more tests," said Lemmo. To meet customer demand, BioDot increased staffing and built a new facility, compressing production time from months to weeks. The FDA recently authorized the first rapid at-home test that can deliver results in 30 minutes, eliminating the need for a lab to test the sample. But the molecular single-use test will only be available to patients with a doctor's prescription who are suspected of being infected with COVID-19.Companies developing tests hope the FDA will soon authorize another at-home testing tool: the rapid antigen test.These inexpensive tests provide results within minutes, and companies developing them say millions could be sold without a doctor's referral.“From what we’re hearing, it’s really just a matter of possibly months before there’s at least sufficient data to be able to support an at-home use of a test like an antigen test," said Lemmo.Lemmo says if authorized by the FDA, manufacturers could make millions of these tests in a matter of months. But antigen tests are less accurate, and the FDA wants to ensure they'll be simple enough for people to use at home. There are also concerns over how the data will be reported to health authorities. “I think any at-home testing or massive rollout of a test into the communities needs to be done very carefully and with a lot of education around it," said Clinical Lab Director Melissa Miller. Dr. Miller is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill and Medical Director for the Clinical Microbiology Lab for the Medical Center.She worries the inaccuracies of these tests could eventually lead the public to lose trust in all testing. “Even at 98 percent specificity, which is very, very high. That means you’re going to have a false positive two out of every 100. If you started testing a hundred million people, this is millions of people who have a false-positive test," said Dr. Miller. She says this could lead to healthy people isolating and missing work or school unnecessarily, and false-negative results could give people a false sense of security. “These rapid antigen tests were pushed out to skilled nursing facilities; this is a very high-risk patient population. This is actually where you want a very accurate test," said Dr. Miller. She says it’s unclear how well antigen tests detect the virus in asymptomatic patients but agrees more data is needed to figure that out.“It might make more sense for K-12 schools, or even college settings, where there’s less risk for a poor outcome if you have a false positive or a false negative," said Dr. Miller. But with a growing demand for convenient at-home testing, manufacturers are hopeful that in the months ahead, the FDA will soon open the door to new solutions. 3889

来源：资阳报